Effects of exogenous p16ink4a gene on biological behaviors of human lung cancer cells

Xiaoju Zhang , Yang Jin , Xiaonan Tao , Ming Bai

Current Medical Science ›› 2007, Vol. 27 ›› Issue (11) : 37 -40.

PDF
Current Medical Science ›› 2007, Vol. 27 ›› Issue (11) : 37 -40. DOI: 10.1007/s11596-007-0111-4
Article

Effects of exogenous p16ink4a gene on biological behaviors of human lung cancer cells

Author information +
History +
PDF

Abstract

The effects of exogenous p16ink4a gene on biological behaviors of human lung cancer cell line with homozygous deletion of p16ink4a gene were investigated. Exogenous p16ink4a gene was transfected by lipofectin into human lung cell line A549, in which p16ink4a gene was homozygously deleted. The expression of p16ink4a mRNA and protein was detected by RT-PCR and immunocyto-chemistry, respectively. The changes in the behaviors of the transfected cell lines in vitro and in vivo were observed. In the transfected cell line A549, the exogenous p16ink4a gene could be stably expressed. The growth of A549 cells transfected with p16ink4a gene was obviously slowed down. Flow cytometry revealed that transfection of the exogenous p16ink4a gene resulted in A549 cell lines arrest in G1 phase of cell cycle. The tumorigenicity of these transfected cells in nude mice could be inhibited, and the tumor growth of nude mice was significantly suppressed. It was concluded that exogenous p16ink4a gene may be stably expressed in human lung cancer cell line A549. The expression of the introduced p16ink4a could block lung cancer cells to entry into S phase of cell cycle and inhibit tumor malignant growth both in vitro and in vivo.

Keywords

lung cancer / p16ink4a gene / transfection / growth inhibition

Cite this article

Download citation ▾
Xiaoju Zhang, Yang Jin, Xiaonan Tao, Ming Bai. Effects of exogenous p16ink4a gene on biological behaviors of human lung cancer cells. Current Medical Science, 2007, 27(11): 37-40 DOI:10.1007/s11596-007-0111-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SalgiaB. R., SkarinA. T.. Molecular abnormalities in lung cancer. J Clin Onco, 1998, 16: 1207-1217

[2]

LiggettW. H.Jr, SidranskyD.. Role of the p16 tumor suppressor gene in cancer. J Clin Onco, 1998, 16(3): 1197-1206

[3]

ShapiroG. I., ParkJ. E., EdwardsC. D., et al.. Multiple mechanisms of p16 inactivation in non-small cell lung cancer cell lines. Cancer Res, 1995, 55: 6200

[4]

Zochbauer-MullerS., FongK. M., VirmaniA. K., et al.. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res, 2001, 61: 249-255

[5]

WolfJ. K., KimT. E., FightmasterT., et al.. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus. Gynecol Oncol, 1999, 73(1): 27-34

[6]

PollockP. M., WelchJ., HaywardN. K.. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res, 2001, 61: 1154-1161

[7]

ThompsonP. M., MarisJ. M., HogartyM. D., et al.. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Cancer Res, 2001, 61: 679-686

[8]

KobayashiS., ShirasawaH., SashiyamaH., et al.. p16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation. Clin Cancer Res, 1999, 5(12): 4182-4185

[9]

BearzattoA., ConteD., FrattiniM., et al.. p16(INK4A) hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res, 2002, 8: 3782-3787

AI Summary AI Mindmap
PDF

98

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/